| Document |
Document Title |
|
JPS627200B2 |
Cardiotonic cardenolide derivatives of the formula wherein n, m, R1 to R9 are as hereinafter defined, the mineral or organic salts thereof and a process for their preparation.
|
|
JPS6214064A |
This disclosure relates to a method and reagents for determining ligands in biological fluids such as serum, plasma, spinal fluid, amnionic fluid and urine. This disclosure also relates to a novel class of tracer compounds employed as re...
|
|
JPS625992A |
The present invention relates to Compounds of formula (VI) or of formula (V) wherein Y sec is hydrogen, hydroxy or an OAc group, wherein Ac is an alkylcarbonyl group having from 1 to 4 carbon atoms in the alkyl moiety, and X is a bromine...
|
|
JPS61502960A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS6150960B2 |
1530975 9,11 - Dihalo - 16 - methyl steroids ROUSSEL UCLAF 2 March 1977 [2 March 1976] 08713/77 Heading C2U The invention comprises compounds of formula (wherein L is H or C 1-18 acyl, and either X is Cl or Br and Y is Cl, or X is Cl and...
|
|
JPS6128100B2 |
A method and reagent means for the determination of small quantities of chemical compounds in man, animal and plants by a specific binding assay technique. The method involves the utilization of a labelling constituent comprising a conju...
|
|
JPS61112095A |
The invention relates to new pregnene derivatives of the general formula (I), (I) wherein R1 stands for a C1-4 alkyl group; R2 stands for a hydrogen atom or a C2-4 alkanoyl group; R3 stands for a hydrogen atom, a hydroxyl group or a C2-4...
|
|
JPS6197298A |
Novel 23-dihydro-oxazolyl steroids of the formula I wherein R1 is selected from the group consisting of hydrogen and methyl, R2 is selected from the group consisting of methyl and ethyl, R3 and R4 are individually selected from the group...
|
|
JPS6118559B2 |
|
|
JPS617292A |
PURPOSE: To obtain the titled compound having strong carcinostatic activity, by reacting the bonding an estracyt compound with a carcinostatic agent having a specific functional group. CONSTITUTION: An estracyt compound [preferably estra...
|
|
JPS60237096A |
A novel process for the preparation of prednisone derivatives of the formula I wherein R1 is alkyl of 1 to 4 carbon atoms and R2 is selected from the group consisting of hydrogen and hydrocarbon of 1 to 8 carbon atoms comprising reacting...
|
|
JPS6050199B2 |
The invention relates to novel spirooxazolidines represented by the formula I (I) wherein R1 is alkyl having from 1 to 4 carbon atoms; R2 is hydrogen, alkyl having from 1 to 4 carbon atoms, alkenyl having from 1 to 4 carbon atoms, or dia...
|
|
JPS60166627A |
Process for the formation of carbon-containing free radicals R., which optionally include functional groups, wherein thermal and/or photochemical energy is supplied to a thiocarbonyl-containing ester corresponding to the general formula ...
|
|
JPS6081121A |
PURPOSE: A cosmetic having hair tonic effect, remedying effect on acne free from side effect, containing 4-androsten-3-one-17β-ethoxy derivative. CONSTITUTION: A cosmetic containing one or more 4-androsten-3-one-17β-ethoxy derivatives ...
|
|
JPS6054310A |
PURPOSE: To provide a cosmetic having excellent hair tonic effect and acne- remedying effect, and free from undesirable side effects such as hormonic activity, by using a specific 4-estren-3-one-17β-ethoxy derivative as an active compon...
|
|
JPS6034989A |
Novel radioactive estradienes labelled with tritium of the formula I wherein 3H is tritium and R is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms and acyl of an organic carboxylic acid of 1 to 10 carbon ato...
|
|
JPS6011499A |
Novel radioactive estradienes labelled with tritium of the formula I wherein 3H is tritium and R is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms and acyl of an organic carboxylic acid of 1 to 10 carbon ato...
|
|
JPS59170769A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS59500914A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS5982399A |
The present application is concerned with compounds useful as carriers of cytotoxic agents. More particularly it deals with derivatives of steroid compounds having a 5-androstene carbon skeleton and having an oleyl ester at the 3-positio...
|
|
JPS5919558B2 |
|
|
JPS5955899A |
21-Hydroxycorticosteroid esters which can have good solution stability and are therefore suitable for formulation into aqueous compositions for injection or infusion, have the formula… St-O-CO-Y-(CH2)n-X-(CH2)m-NR1R2… wherein St is t...
|
|
JPS5955900A |
21-Hydroxycorticosteroid esters which can have good solution stability and are therefore suitable for formulation into aqueous compositions for injection or infusion, have the formula St-O-CO-Y-(CH2)n-NR1R2 wherein St is the corticostero...
|
|
JPS5946300A |
NEW MATERIAL:The novel cholic acid derivative of formula I [R1 and R2 are H or OH (when R1 is OH and R2 is H, the steric configuration may be α or β; when both R1 and R2 are OH, it is α; and when R2 is OH, it is always α); R is group...
|
|
JPS597720B2 |
New triamino-androstanes with curare-type properties and a process for the preparation thereof are disclosed.
|
|
JPS591279B2 |
|
|
JPS58216200A |
Topical antiinflammatory activity is exhibited by steroids having the formulaand the 1,2-dehydro and 15,16-dehydro derivatives thereof, whereinR1 is hydrogen, alkyl, carboxyl, oralkoxycarbonyl;R2 is hydrogen, chlorine, bromine, fluorine,...
|
|
JPS58214856A |
There is described an enzyme immunoassay for measuring the concentration of an analyte in a sample wherein the substrate for the enzyme forms at least a part of the sample. In a particular embodiment the sample comprises or consists of a...
|
|
JPS5855160B2 |
New reactive asymmetrical dicarboxylic acid ester compounds of the formula (I) wherein R1 is an alkyl radical containing up to 3 carbon atoms or is a digoxin or digitoxin residue, R2 and R3, which may be the same or different, are alkoxy...
|
|
JPS5851626B2 |
Radio-iodine derivatives of digoxin and digitoxin are provided having the formula IV, where R is H or lower alkyl N IS 1, 2 OR 3 Y is H or carboxyl M IS 0 TO 5, AND Q is a phenolic or imidazole ring, TO WHICH RADIO-IODINE ATOMS ARE ATTAC...
|
|
JPS5842199B2 |
1452794 Estriol nicotinates THERAMEX SA 26 Feb 1975 [26 Feb 1974] 8712/74 Heading C2U The invention comprises compounds of formula (wherein R is nicotinoyl or its N-oxide; and R1 is C 3-7 aliphatic organic acyl; aromatic, alicyclic or he...
|
|
JPS5842198B2 |
|
|
JPS5877898A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS5877900A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS5874697A |
8alpha-Oestratrienes of formula (I) are new, (where X is O or R1 and R3 are H, acyl, (cyclo)-alkyl or a satd. O-contg. heterocyclic gp; R2 is lower alkyl; and R4 is H or opt. unsatd., (substd.) hydrocarbyl). (I) have potent vaginotropic ...
|
|
JPS5821639B2 |
1,3-Dihydroxy-1,3,5(10)-8alpha-oestratrienes or their ethers or esters of the following formula in which the substituents are defined in Claim 1 are prepared. The said compounds are obtained by hydrogenating the 8(9) and, if present, the...
|
|
JPS5810400B2 |
|
|
JPS5810394B2 |
NEW MATERIAL:An addition compound of formula composed of an estradiol derivative and streptozotocin. USE:Anti-tumor agent having selectivity to cancer cells having receptors, and low side effects. Especially effective to breast cancer, s...
|
|
JPS5810398B2 |
|
|
JPS5810399B2 |
|
|
JPS589119B2 |
|
|
JPS5758357B2 |
|
|
JPS57134466A |
Novel pharmaceutically useful derivatives of selected known bio-affecting carboxylic acids are disclosed, said derivatives having the structural formula (I) wherein R1 and R2, which can be the same or different, are each hydrogen, C1-C5 ...
|
|
JPS57114599A |
Immunologic adjuvants are obtained by the synthesis of 6-(5-cholesten-3#-yloxy)hexyl 6-amino-6-deoxy-1-thio-β-D-galactopyranoside and its 6-deoxy-6-oleamido derivative.
|
|
JPS57106647A |
Derivatives of known bio-affecting carboxylic acids, their non-toxic pharmaceuticaily acceptable acid addition salts and N-oxides as well as processes for preparing those novel derivatives are disclosed. Those derivatives having the stru...
|
|
JPS5725560B2 |
1409239 3α-Hydroxy-steroids GLAXO LABORATORIES Ltd 8 Nov 1972 [11 Nov 1971] 52465/71 Heading C2U 3α-Hydroxy-5α-steroids, including the novel 3α - hydroxy - 19 - nor - 5α - pregnan - 20 - one, are prepared by reducing 3-oxo-5α-stero...
|
|
JPS56147800A |
NEW MATERIAL:N1-Cholesteryloxycarbonyl-5-fluorouracil. USE: A carcinostatic agent. Having a small side effect and good absorption. PROCESS: For example, 5-fluorouracil is reacted with chloroformic ester of cholesterol in the presence of ...
|
|
JPS5647200B1 |
1365229 17 - Cyanosteroids ROUSSEL UCLAF 1 June 1972 [1 June 1971] 25576/72 Heading C2U The invention comprises compounds of Formula Ia, Ib, Ic, VI, VII, VIII and IX in the following reaction scheme wherein all conversions are effected i...
|
|
JPS56142300A |
New steroid-spiro-oxathiazolidine derivatives pharmaceutical compositions containing the same, and to a process for the preparation thereof are disclosed. The new compounds have antimineral corticoide effects and have the following formu...
|
|
JPS56124000A |
Compounds of the formula (I) having aldosterone-antagonizing activity are disclosed (I) wherein R3 and R4 are each C1 to C3 alkyl; and Z is one of the following groups (a) (b) (c) (d) (e) wherein R1 is hydrogen or methyl; R6 is hydrogen,...
|
